Prospective Validation of the Association Between Circulating Tumor DNA Detection and Risk of Metastatic Relapse in Patients With Localized Endometrial Cancer
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The objective of this study is to identify a population at risk of early recurrence after oncologic resection surgery of a primary uterine tumor based on the detection of ctDNA
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Female patients over 18 years of age who are potentially eligible for inclusion in the OncoCentre collection (registered as a patient at APHP, without legal protection measures, affiliated with a social security system)
• Patients diagnosed with histologically documented endometrial cancer on an endometrial biopsy
• Surgical intervention performed at Hopital Cochin
Locations
Other Locations
France
Hôpital Cochin
RECRUITING
Paris
Contact Information
Primary
Guillaume BEINSE, MD, PhD
guillaume.beinse@aphp.fr
+33 1 58 41 14 54
Backup
Laetitia PEAUDECERF
laetitia.peaudecerf@aphp.fr
+33 1 58 41 12 13
Time Frame
Start Date: 2021-01-01
Estimated Completion Date: 2026-01
Participants
Target number of participants: 130
Treatments
Endometrial Cancer
Patients over 18 years old with a biopsy-proven endometrial cancer, at FIGO stage I to IV, and amenable and undergoing surgical treatment
Related Therapeutic Areas
Sponsors
Collaborators: METHYS DX, CARPEM, Institut du Cancer Paris, Centre de recherche des Cordeliers
Leads: Assistance Publique - Hôpitaux de Paris